Last updated at 15 Jul 2024 04:35 PM
Director
DIN: 08485240
Sasidharan Achuthan is currently associated with 2 companies in various capacities such as Individual Promoter and Director. They serve as a Director at SRI CHAKRA INSTITUTE OF MEDICAL SCIENCE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08485240.Sasidharan Achuthan is currently involved in 2 different roles. Their most recent position is with SRESHTATHA PRIVATE LIMITED as a Director. The first company Sasidharan Achuthan was appointed to as a director was SRI CHAKRA INSTITUTE OF MEDICAL SCIENCE PRIVATE LIMITED. Sasidharan Achuthan has a status of Deactivated. Please verify the details for any specific requirements or conditions.
Sasidharan Achuthan is currently associated with 2 companies in various capacities such as Individual Promoter and Director. They serve as a Director at SRI CHAKRA INSTITUTE OF MEDICAL SCIENCE PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08485240.Sasidharan Achuthan is currently involved in 2 different roles. Their most recent position is with SRESHTATHA PRIVATE LIMITED as a Director. The first company Sasidharan Achuthan was appointed to as a director was SRI CHAKRA INSTITUTE OF MEDICAL SCIENCE PRIVATE LIMITED. Sasidharan Achuthan has a status of Deactivated. Please verify the details for any specific requirements or conditions.
4
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
1y 4m 8 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| SRI CHAKRA INSTITUTE OF MEDICAL SCIENCE PRIVATE LIMITED | Individual Promoter | 17-Jun-2019 |
| SRI CHAKRA INSTITUTE OF MEDICAL SCIENCE PRIVATE LIMITED | Director | 17-Jun-2019 |
| SRESHTATHA PRIVATE LIMITED | Director | 28-Sep-2020 |
| SRESHTATHA PRIVATE LIMITED | Individual Promoter | 28-Sep-2020 |